Search

Author/Creator Compston, D. Alastair S.

1. Alemtuzumab CARE-MS I 5-year follow-up: Durable efficacy in the absence of continuous MS therapy. (12th September 2017)

Authors:
Havrdova, Eva; Arnold, Douglas L.; Cohen, Jeffrey A.; Hartung, Hans-Peter; Fox, Edward J.; Giovannoni, Gavin; Schippling, Sven; Selmaj, Krzysztof W.; Traboulsee, Anthony; Compston, D. Alastair S.; Margolin, David H.; Thangavelu, Karthinathan; Rodriguez, Claudio E.; Jody, Darlene; Hogan, Richard J...
Journal:
Neurology
Issue:
Volume 89:Number 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings. (12th September 2017)

Authors:
Coles, Alasdair J.; Cohen, Jeffrey A.; Fox, Edward J.; Giovannoni, Gavin; Hartung, Hans-Peter; Havrdova, Eva; Schippling, Sven; Selmaj, Krzysztof W.; Traboulsee, Anthony; Compston, D. Alastair S.; Margolin, David H.; Thangavelu, Karthinathan; Chirieac, Madalina C.; Jody, Darlene; Xenopoulos, Pano...
Journal:
Neurology
Issue:
Volume 89:Number 11(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients. (8th November 2016)

Authors:
Giovannoni, Gavin; Cohen, Jeffrey A.; Coles, Alasdair J.; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W.; Margolin, David H.; Lake, Stephen L.; Kaup, Susan M.; Panzara, Michael A.; Compston, D. Alastair S.
Journal:
Neurology
Issue:
Volume 87:Number 19(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial. (April 2021)

Authors:
Coles, Alasdair J.; Arnold, Douglas L.; Bass, Ann D.; Boster, Aaron L.; Compston, D. Alastair S.; Fernández, Óscar; Havrdová, Eva Kubala; Nakamura, Kunio; Traboulsee, Anthony; Ziemssen, Tjalf; Jacobs, Alan; Margolin, David H.; Huang, Xiaobi; Daizadeh, Nadia; Chirieac, Madalina C.; Selmaj, Krzyszt...
Journal:
Therapeutic advances in neurological disorders
Issue:
Volume 14(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS. (4th October 2016)

Authors:
Arnold, Douglas L.; Fisher, Elizabeth; Brinar, Vesna V.; Cohen, Jeffrey A.; Coles, Alasdair J.; Giovannoni, Gavin; Hartung, Hans-Peter; Havrdova, Eva; Selmaj, Krzysztof W.; Stojanovic, Miroslav; Weiner, Howard L.; Lake, Stephen L.; Margolin, David H.; Thomas, David R.; Panzara, Michael A.; Compst...
Journal:
Neurology
Issue:
Volume 87:Number 14(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗